These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38414029)

  • 21. Characterization of the P373L E-cadherin germline missense mutation and implication for clinical management.
    Corso G; Roviello F; Paredes J; Pedrazzani C; Novais M; Correia J; Marrelli D; Cirnes L; Seruca R; Oliveira C; Suriano G
    Eur J Surg Oncol; 2007 Nov; 33(9):1061-7. PubMed ID: 17434710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deregulated Adhesion Program in Palatal Keratinocytes of Orofacial Cleft Patients.
    Mammadova A; Carels CEL; Zhou J; Gilissen C; Helmich MPAC; Bian Z; Zhou H; Von den Hoff JW
    Genes (Basel); 2019 Oct; 10(11):. PubMed ID: 31652793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TPA-induced cohort migration of well-differentiated human rectal adenocarcinoma cells: cells move in a RGD-dependent manner on fibronectin produced by cells, and phosphorylation of E-cadherin/catenin complex is induced independently of cell-extracellular matrix interactions.
    Nabeshima K; Inoue T; Shimao Y; Kataoka H; Koono M
    Virchows Arch; 1998 Sep; 433(3):243-53. PubMed ID: 9769128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms and sequelae of E-cadherin silencing in hereditary diffuse gastric cancer.
    Barber M; Murrell A; Ito Y; Maia AT; Hyland S; Oliveira C; Save V; Carneiro F; Paterson AL; Grehan N; Dwerryhouse S; Lao-Sirieix P; Caldas C; Fitzgerald RC
    J Pathol; 2008 Nov; 216(3):295-306. PubMed ID: 18788075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cleft lip/palate and hereditary diffuse gastric cancer: report of a family harboring a CDH1 c.687 + 1G > A germline mutation and review of the literature.
    Obermair F; Rammer M; Burghofer J; Malli T; Schossig A; Wimmer K; Kranewitter W; Mayrbaeurl B; Duba HC; Webersinke G
    Fam Cancer; 2019 Apr; 18(2):253-260. PubMed ID: 30306390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantification of mutant E-cadherin using bioimaging analysis of in situ fluorescence microscopy. A new approach to CDH1 missense variants.
    Sanches JM; Figueiredo J; Fonseca M; Durães C; Melo S; Esménio S; Seruca R
    Eur J Hum Genet; 2015 Aug; 23(8):1072-9. PubMed ID: 25388006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel mutation in the E-cadherin gene in the first family with hereditary diffuse gastric cancer reported in Spain.
    Rodriguez-Sanjuan JC; Fontalba A; Mayorga M; Bordin MC; Hyland SJ; Trugeda S; Garcia RA; Gomez-Fleitas M; Fernandez F; Caldas C; Fernandez-Luna JL
    Eur J Surg Oncol; 2006 Dec; 32(10):1110-3. PubMed ID: 16870389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The intracellular E-cadherin germline mutation V832 M lacks the ability to mediate cell-cell adhesion and to suppress invasion.
    Suriano G; Mulholland D; de Wever O; Ferreira P; Mateus AR; Bruyneel E; Nelson CC; Mareel MM; Yokota J; Huntsman D; Seruca R
    Oncogene; 2003 Aug; 22(36):5716-9. PubMed ID: 12944922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A high-throughput screen to identify novel synthetic lethal compounds for the treatment of E-cadherin-deficient cells.
    Beetham H; Chen A; Telford BJ; Single A; Jarman KE; Lackovic K; Luxenburger A; Guilford P
    Sci Rep; 2019 Aug; 9(1):12511. PubMed ID: 31467357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The NMD mRNA surveillance pathway downregulates aberrant E-cadherin transcripts in gastric cancer cells and in CDH1 mutation carriers.
    Karam R; Carvalho J; Bruno I; Graziadio C; Senz J; Huntsman D; Carneiro F; Seruca R; Wilkinson MF; Oliveira C
    Oncogene; 2008 Jul; 27(30):4255-60. PubMed ID: 18427545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamics of cell adhesion and motility in living cells is altered by a single amino acid change in E-cadherin fused to enhanced green fluorescent protein.
    Fuchs M; Hutzler P; Handschuh G; Hermannstädter C; Brunner I; Höfler H; Luber B
    Cell Motil Cytoskeleton; 2004 Sep; 59(1):50-61. PubMed ID: 15259055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond.
    Hansford S; Kaurah P; Li-Chang H; Woo M; Senz J; Pinheiro H; Schrader KA; Schaeffer DF; Shumansky K; Zogopoulos G; Santos TA; Claro I; Carvalho J; Nielsen C; Padilla S; Lum A; Talhouk A; Baker-Lange K; Richardson S; Lewis I; Lindor NM; Pennell E; MacMillan A; Fernandez B; Keller G; Lynch H; Shah SP; Guilford P; Gallinger S; Corso G; Roviello F; Caldas C; Oliveira C; Pharoah PD; Huntsman DG
    JAMA Oncol; 2015 Apr; 1(1):23-32. PubMed ID: 26182300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CDH1 germline mutations in a Chinese cohort with hereditary diffuse gastric cancer.
    Pan Z; Fu Z; Luo C; Bao Y; Wang M; Cao W; Xu X
    J Cancer Res Clin Oncol; 2022 Aug; 148(8):2145-2151. PubMed ID: 34537906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands.
    Suriano G; Oliveira C; Ferreira P; Machado JC; Bordin MC; De Wever O; Bruyneel EA; Moguilevsky N; Grehan N; Porter TR; Richards FM; Hruban RH; Roviello F; Huntsman D; Mareel M; Carneiro F; Caldas C; Seruca R
    Hum Mol Genet; 2003 Mar; 12(5):575-82. PubMed ID: 12588804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined loss of CDH1 and downstream regulatory sequences drive early-onset diffuse gastric cancer and increase penetrance of hereditary diffuse gastric cancer.
    São José C; Garcia-Pelaez J; Ferreira M; Arrieta O; André A; Martins N; Solís S; Martínez-Benítez B; Ordóñez-Sánchez ML; Rodríguez-Torres M; Sommer AK; Te Paske IBAW; Caldas C; Tischkowitz M; Tusié MT; ; Hoogerbrugge N; Demidov G; de Voer RM; Laurie S; Oliveira C
    Gastric Cancer; 2023 Sep; 26(5):653-666. PubMed ID: 37249750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Germline likely pathogenic variants in ataxia-telangiectasia-mutated gene in an Iranian family with hereditary diffuse gastric cancer without
    Kheirollahi M; Saneipour M; Moridnia A
    J Cancer Res Ther; 2021; 17(6):1434-1437. PubMed ID: 34916374
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Motility enhancement by tumor-derived mutant E-cadherin is sensitive to treatment with epidermal growth factor receptor and phosphatidylinositol 3-kinase inhibitors.
    Fuchs M; Hutzler P; Brunner I; Schlegel J; Mages J; Reuning U; Hapke S; Duyster J; Hirohashi S; Genda T; Sakamoto M; Uberall F; Höfler H; Becker KF; Luber B
    Exp Cell Res; 2002 Jun; 276(2):129-41. PubMed ID: 12027444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E-cadherin and gastric cancer: cause, consequence, and applications.
    Liu X; Chu KM
    Biomed Res Int; 2014; 2014():637308. PubMed ID: 25184143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. E-cadherin dysfunction in gastric cancer--cellular consequences, clinical applications and open questions.
    Carneiro P; Fernandes MS; Figueiredo J; Caldeira J; Carvalho J; Pinheiro H; Leite M; Melo S; Oliveira P; Simões-Correia J; Oliveira MJ; Carneiro F; Figueiredo C; Paredes J; Oliveira C; Seruca R
    FEBS Lett; 2012 Aug; 586(18):2981-9. PubMed ID: 22841718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EGFR regulates RhoA-GTP dependent cell motility in E-cadherin mutant cells.
    Mateus AR; Seruca R; Machado JC; Keller G; Oliveira MJ; Suriano G; Luber B
    Hum Mol Genet; 2007 Jul; 16(13):1639-47. PubMed ID: 17510211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.